Tonix Pharmaceuticals Holding Corp (TNXP) Company Profile & Statistics

Tonix Pharmaceuticals Holding Corp
TNXP
(Nasdaq - US)
Closed
0.19
-0.02 (-7.39%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
After Market:0.18-0.01 (-4.81%)
Open
0.20
High
0.21
Low
0.19

About Tonix Pharmaceuticals Holding Corp

CEO

Seth Lederman

Headquarters

26 main street, suite 101

chatham, nj 07928, united states

Auditor

EISNERAMPER LLP

Employees

Share Holders

228

Website

www.tonixpharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.

Tonix Pharmaceuticals Holding Corp Statistics

Valuation Measures

Market Capitalization ²	25.96M
Enterprise Value	5.71M
Enterprise Value/EBITDA (ttm)	-0.04
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.48
Price to Sales (ttm)	3.14
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	15.72%
Operating Margin (ttm)	-1197.86%
Profit Margin (ttm)	-1349.07%
Return on Equity (ttm)	-163.95%
Return on Invested Capital (ttm)	-220.25%
Return on Assets (ttm)	-118.88%

Income Statement

Revenue (ttm)	11.29M
Revenue Per Share (ttm)	0.06
Gross Profit (ttm)	2.34M
EBITDA (ttm)³	-136.72M
Net Income Avi to Common (ttm)	-135.25M
Diluted EPS (ttm)	-52.74

Share Statistics

Beta (5Y Monthly)	2.06
52-Week Change	-98.77%
S&P500 52-Week Change	30.93%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	186.89M
Dividend Yield	0.00%
Float ⁴	186.82M
% Held by Insiders	0.04%
% Held by Institutions	82.26%

Balance Sheet

Total Cash (mrq)	28.23M
Total Cash Per Share (mrq)	0.15
Total Debt (mrq)	7.99M
Total Debt/Equity (mrq)	10.77%
Current Ratio (mrq)	3.33%
Quick Ratio (mrq)	2.81%
Book Value Per Share (mrq)	0.48

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.75
Free Cash Flow (ytd)	-46.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Tonix Pharmaceuticals Holding Corp

Trade With A Regulated Broker